Tufton Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.89M | Sell |
67,537
-1,914
| -3% | -$167K | 1.12% | 37 |
|
|
2025
Q1 | $6.24M | Sell |
69,451
-110
| -0.2% | -$9.89K | 1.2% | 35 |
|
|
2024
Q4 | $5.56M | Sell |
69,561
-1,692
| -2% | -$135K | 1.05% | 38 |
|
|
2024
Q3 | $6.41M | Sell |
71,253
-4,223
| -6% | -$380K | 1.2% | 34 |
|
|
2024
Q2 | $5.94M | Sell |
75,476
-96
| -0.1% | -$7.56K | 1.16% | 35 |
|
|
2024
Q1 | $6.59M | Sell |
75,572
-143
| -0.2% | -$12.5K | 1.29% | 33 |
|
|
2023
Q4 | $6.24M | Sell |
75,715
-3,150
| -4% | -$259K | 1.31% | 34 |
|
|
2023
Q3 | $6.18M | Buy |
78,865
+1,070
| +1% | +$83.8K | 1.38% | 32 |
|
|
2023
Q2 | $6.85M | Buy |
77,795
+7,279
| +10% | +$641K | 1.48% | 32 |
|
|
2023
Q1 | $5.68M | Buy |
70,516
+8,936
| +15% | +$720K | 1.23% | 35 |
|
|
2022
Q4 | $4.79M | Sell |
61,580
-165
| -0.3% | -$12.8K | 1.05% | 40 |
|
|
2022
Q3 | $4.99M | Buy |
61,745
+605
| +1% | +$48.8K | 1.2% | 36 |
|
|
2022
Q2 | $5.49M | Buy |
61,140
+5,295
| +9% | +$475K | 1.03% | 41 |
|
|
2022
Q1 | $6.2M | Buy |
55,845
+49,242
| +746% | +$5.46M | 1% | 41 |
|
|
2021
Q4 | $683K | Buy |
6,603
+285
| +5% | +$29.5K | 0.1% | 86 |
|
|
2021
Q3 | $791K | Buy |
6,318
+102
| +2% | +$12.8K | 0.13% | 80 |
|
|
2021
Q2 | $771K | Buy |
6,216
+2,150
| +53% | +$267K | 0.13% | 82 |
|
|
2021
Q1 | $480K | Sell |
4,066
-19
| -0.5% | -$2.24K | 0.08% | 93 |
|
|
2020
Q4 | $478K | Buy |
4,085
+700
| +21% | +$81.9K | 0.09% | 91 |
|
|
2020
Q3 | $351K | Buy |
+3,385
| New | +$351K | 0.07% | 99 |
|